Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma
Status:
Recruiting
Trial end date:
2024-12-31
Target enrollment:
Participant gender:
Summary
Hepatic hemangioma is one of the most common benign tumor of the liver. Although the overall
prognosis is good, active interventions are still needed in high-risk patients. Without
specific drugs, the main treatment methods include surgical treatments, interventional
therapies and radiotherapies. Effective medical treatments are needed urgently. Propranolol
has achieved good results in infantile Facial/hepatic hemangioma, and shows some
effectiveness in adult hemangioma. Here, investigators intend to evaluate the therapeutic
effect of propranolol in adult hepatic hemangioma.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University